Exact Mass: 604.3012334
Exact Mass Matches: 604.3012334
Found 370 metabolites which its exact mass value is equals to given mass value 604.3012334
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
6-Hydroxysandoricin
6-Hydroxysandoricin is a constituent of Sandoricum koetjape (santol).
[(S)-1-Carboxy-2-phenyl-ethyl]-carbamoyl-Arg-Val-Arg-aldehyde
Dilazep
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
Telinavir
methyl-ent-15alpha-acetoxy-1alpha-(2-methyl-2,3-epoxybutyryloxy)-9alpha-hydroxy-7alpha-isovaleryloxykaur-16-en-19-oate|methyl-ent-15alpha-acetoxy-1alpha-<2-methyl-2,3-epoxybutyryloxy>-9alpha-hydroxy-7alpha-isovaleryloxykaur-16-en-19-oate
4-[4-((R)-alpha-amino-beta-hydroxy-isobutyrylamino)-benzoylamino]-1-[O4-(4-methylamino-4,6-dideoxy-alpha-D-glucopyranosyl)-beta-D-erythro-2,3,6-trideoxy-hexopyranosyl]-1H-pyrimidin-2-one|4-[4-((R)-alpha-Amino-beta-hydroxy-isobutyrylamino)-benzoylamino]-1-[O4-(4-methylamino-4,6-didesoxy-alpha-D-glucopyranosyl)-beta-D-erythro-2,3,6-tridesoxy-hexopyranosyl]-1H-pyrimidin-2-on|bamicetin
12beta.21-Di-O-benzoyl-viminolon (Genin-H)|Di-O-benzoyl-viminolon
(1S,2S,3S,4S,4aR,4bR,5aS,6R,6aR,9aR,9bR)-1,2,3,4,4a,4b,5a,6,6a,7,9a,9b-dodecahydro-3,6,6a,9b-tetrahydroxy-5a-(hydroxymethyl)-1,8-dimethyl-3-(1-methylethenyl)-7-oxo-2-(1-oxopropoxy)benz[7,8]azuleno[5,6-b]oxiren-4-yl (2E,4E)-deca-2,4-dienoate|yuanhuaoate C
(1aS,1bR,2aS,3aS,4R,4aS,6S,6aS,7R,8R,11R,12S,13cS)-4,6-bis(acetyloxy)icosahydro-1b,11-dihydroxy-7-(hydroxymethyl)-4a,6a,11,12-tetramethyl-8,12-methanobisoxireno[3,4:6,7]naphtho[2,1:4,5]indeno[1,2-d]oxocin-10(2H)-one|taccalonolide Y
6-Hydroxysandoricin
16beta-acetoxystrophanthidin-4,6-dideoxy-2,3-methylenedioxy-beta-D-allopyranoside|reevesioside B
1beta,2beta-diacetoxy-6alpha-benzoyloxy-beta-dihydroagarofuran
(1R*,3S*,5S*,6aR*,7R*,8R*,9S*,10S*,10aR*)-1,10-bis(acetyloxy)-5-methoxy-7,8-dimethyl-7-[(2Z)-3-methylpenta-2,4-dien-1-yl]-3,5,6,6a,7,8,9,10-octahydronaphtho[1,8a-c]furan-3,9-diyl dibutanoate
caseamembrin R|rel-(2S,5R,6S,7R,8S,9S,10R,18S,19R)-2-(2-methylbutanoyloxy)-18-butanoyloxy-7,19-diacetoxy-18,19-epoxy-6,7-dihydroxy-cleroda-3,13(16),14-triene
maireine A|methyl (5alpha,12beta,19alpha)-2,3-didehydro-16-methoxy-20-{[(2E)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}aspidospermidine-3-carboxylate
16beta-O-acetyl-scillarenin-3-O-beta-D-glucoside|3-O-beta-Glucopyranoside,16-Ac-3,14,16-Trohydroxybufa-4,20,22-trienolide
cinobufagin 3-O-beta-D-glucopyranoside|cinobufagin 3-O-beta-D-glucoside
C33H48O10_(2alpha,5alpha,9alpha,10beta,14beta)-2,5,9,10-Tetraacetoxytaxa-4(20),11-dien-14-yl 2-methylbutanoate
C31H40O12_Butanoic acid, 2-methyl-, 9-(3-furanyl)decahydro-2,6,8,9,14-pentahydroxy-3,8a-dimethyl-7-oxo-12H,13aH-3,6a,11b-[1,1,3]propanetriyl-2H,8H-oxireno[3,3a]indeno[5,4:4,5]pyrano[2,3-b]oxocin-4-yl ester
6-(furan-3-yl)-6,8,12,16,21-pentahydroxy-7,15-dimethyl-9-oxo-3,17,19-trioxaheptacyclo[9.9.3.0¹,¹⁰.0²,⁴.0²,⁷.0¹¹,¹⁸.0¹⁵,²³]tricosan-14-yl 2-methylbutanoate
6-(furan-3-yl)-6,8,12,16,21-pentahydroxy-7,15-dimethyl-9-oxo-3,17,19-trioxaheptacyclo[9.9.3.0¹,¹⁰.0²,⁴.0²,⁷.0¹¹,¹⁸.0¹⁵,²³]tricosan-14-yl 2-methylbutanoate_major
Asp Glu Arg Trp
Asp Glu Trp Arg
Asp Arg Glu Trp
Asp Arg Trp Glu
Asp Val Trp Trp
C31H36N6O7 (604.2645345999999)
Asp Trp Glu Arg
Asp Trp Arg Glu
Asp Trp Val Trp
C31H36N6O7 (604.2645345999999)
Asp Trp Trp Val
C31H36N6O7 (604.2645345999999)
Glu Asp Arg Trp
Glu Asp Trp Arg
Glu Phe Phe Tyr
Glu Phe Tyr Phe
Glu Arg Asp Trp
Glu Arg Trp Asp
Glu Trp Asp Arg
Glu Trp Arg Asp
Glu Tyr Phe Phe
Phe Glu Phe Tyr
Phe Glu Tyr Phe
Phe Phe Glu Tyr
Phe Phe Tyr Glu
Phe Ile Tyr Tyr
Phe Leu Tyr Tyr
Phe Pro Arg Trp
Phe Pro Trp Arg
Phe Arg Pro Trp
Phe Arg Trp Pro
Phe Trp Pro Arg
Phe Trp Arg Pro
Phe Tyr Glu Phe
Phe Tyr Phe Glu
Phe Tyr Ile Tyr
Phe Tyr Leu Tyr
Phe Tyr Tyr Ile
Phe Tyr Tyr Leu
His His Arg Arg
His Arg His Arg
His Arg Arg His
Ile Phe Tyr Tyr
Ile Met Arg Trp
Ile Met Trp Arg
Ile Arg Met Trp
Ile Arg Trp Met
Ile Thr Trp Trp
Ile Trp Met Arg
Ile Trp Arg Met
Ile Trp Thr Trp
Ile Trp Trp Thr
Ile Tyr Phe Tyr
Ile Tyr Tyr Phe
Leu Phe Tyr Tyr
Leu Met Arg Trp
Leu Met Trp Arg
Leu Arg Met Trp
Leu Arg Trp Met
Leu Thr Trp Trp
Leu Trp Met Arg
Leu Trp Arg Met
Leu Trp Thr Trp
Leu Trp Trp Thr
Leu Tyr Phe Tyr
Leu Tyr Tyr Phe
Met Ile Arg Trp
Met Ile Trp Arg
Met Leu Arg Trp
Met Leu Trp Arg
Met Arg Ile Trp
Met Arg Leu Trp
Met Arg Trp Ile
Met Arg Trp Leu
Met Trp Ile Arg
Met Trp Leu Arg
Met Trp Arg Ile
Met Trp Arg Leu
Pro Phe Arg Trp
Pro Phe Trp Arg
Pro Arg Phe Trp
Pro Arg Trp Phe
Pro Trp Phe Arg
Pro Trp Arg Phe
Pro Tyr Tyr Tyr
Arg Asp Glu Trp
Arg Asp Trp Glu
Arg Glu Asp Trp
Arg Glu Trp Asp
Arg Phe Pro Trp
Arg Phe Trp Pro
Arg His His Arg
Arg His Arg His
Arg Ile Met Trp
Arg Ile Trp Met
Arg Leu Met Trp
Arg Leu Trp Met
Arg Met Ile Trp
Arg Met Leu Trp
Arg Met Trp Ile
Arg Met Trp Leu
Arg Pro Phe Trp
Arg Pro Trp Phe
Arg Arg His His
Arg Trp Asp Glu
Arg Trp Glu Asp
Arg Trp Phe Pro
Arg Trp Ile Met
Arg Trp Leu Met
Arg Trp Met Ile
Arg Trp Met Leu
Arg Trp Pro Phe
Thr Ile Trp Trp
Thr Leu Trp Trp
Thr Trp Ile Trp
Thr Trp Leu Trp
Thr Trp Trp Ile
Thr Trp Trp Leu
Val Asp Trp Trp
C31H36N6O7 (604.2645345999999)
Val Trp Asp Trp
C31H36N6O7 (604.2645345999999)
Val Trp Trp Asp
C31H36N6O7 (604.2645345999999)
Trp Asp Glu Arg
Trp Asp Arg Glu
Trp Asp Val Trp
C31H36N6O7 (604.2645345999999)
Trp Asp Trp Val
C31H36N6O7 (604.2645345999999)
Trp Glu Asp Arg
Trp Glu Arg Asp
Trp Phe Pro Arg
Trp Phe Arg Pro
Trp Ile Met Arg
Trp Ile Arg Met
Trp Ile Thr Trp
Trp Ile Trp Thr
Trp Leu Met Arg
Trp Leu Arg Met
Trp Leu Thr Trp
Trp Leu Trp Thr
Trp Met Ile Arg
Trp Met Leu Arg
Trp Met Arg Ile
Trp Met Arg Leu
Trp Pro Phe Arg
Trp Pro Arg Phe
Trp Arg Asp Glu
Trp Arg Glu Asp
Trp Arg Phe Pro
Trp Arg Ile Met
Trp Arg Leu Met
Trp Arg Met Ile
Trp Arg Met Leu
Trp Arg Pro Phe
Trp Thr Ile Trp
Trp Thr Leu Trp
Trp Thr Trp Ile
Trp Thr Trp Leu
Trp Val Asp Trp
C31H36N6O7 (604.2645345999999)
Trp Val Trp Asp
C31H36N6O7 (604.2645345999999)
Trp Trp Asp Val
C31H36N6O7 (604.2645345999999)
Trp Trp Ile Thr
Trp Trp Leu Thr
Trp Trp Thr Ile
Trp Trp Thr Leu
Trp Trp Val Asp
C31H36N6O7 (604.2645345999999)
Tyr Glu Phe Phe
Tyr Phe Glu Phe
Tyr Phe Phe Glu
Tyr Phe Ile Tyr
Tyr Phe Leu Tyr
Tyr Phe Tyr Ile
Tyr Phe Tyr Leu
Tyr Ile Phe Tyr
Tyr Ile Tyr Phe
Tyr Leu Phe Tyr
Tyr Leu Tyr Phe
Tyr Pro Tyr Tyr
Tyr Tyr Phe Ile
Tyr Tyr Phe Leu
Tyr Tyr Ile Phe
Tyr Tyr Leu Phe
Tyr Tyr Pro Tyr
Tyr Tyr Tyr Pro
ST 26:6;O6;Hex
Telinavir
C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C97366 - HIV Protease Inhibitor C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent
N,N-Di(4-biphenylyl)-N-(9,9-dimethyl-9H-fluoren-2-yl)-1,4-benzen ediamine
2,4,8,10-Tetraoxa-3,9-diphosphaspiro[5.5]undecane, 3,9-bis[2,4-bis(1,1-dimethylethyl)phenoxy]-
Quarfloxin
C471 - Enzyme Inhibitor > C25995 - RNA Polymerase Inhibitor C254 - Anti-Infective Agent > C52588 - Antibacterial Agent
butane-1,4-diol,hexanedioic acid,hexane-1,6-diol,1-isocyanato-4-[(4-isocyanatophenyl)methyl]benzene
N,N-Bis[4-(diethylamino)phenyl]-N,N-diethyl-1,4-benzenediamine hexafluorophosphate
N~1~-{4-[(tert-Butylcarbamoyl)(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(quinoline-2-carbonyl)aspartamide
Withalongolide M
A steroid saponin that is the monosaccharide derivative of the 19-norwithanolide. It has been isolated from the aerial parts of Physalis longifolia.
Withalongolide N
A steroid saponin that is the monosaccharide derivative of the 19-norwithanolide. It has been isolated from the aerial parts of Physalis longifolia.
(2S)-2-[12-ethyl-8-(hydroxymethyl)-9-oxo-2-(4-piperidin-1-ylpiperidine-1-carbonyl)oxy-11H-indolizino[1,2-b]quinolin-7-yl]-2-hydroxybutanoic acid
Dilazep
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist C - Cardiovascular system > C01 - Cardiac therapy > C01D - Vasodilators used in cardiac diseases D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents
[(1S,2R,3R,4S,5R)-5-azaniumyl-3-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-azaniumyl-6-(azaniumylmethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-2-[(2S,3R,5S,6R)-3-azaniumyl-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4-hydroxycyclohexyl]azanium
(2S,3S,4S,5Z)-4-(2-carboxyethyl)-5-[2-[[5-[(3-ethenyl-4-methyl-5-oxo-1,2-dihydropyrrol-2-yl)methyl]-3-ethyl-4-methyl-1H-pyrrol-2-yl]methyl]-3-methyl-4,5-dioxo-3a,6a-dihydro-1H-cyclopenta[b]pyrrol-6-ylidene]-3-methylpyrrolidine-2-carboxylic acid
Asp-Trp-Trp-Val
C31H36N6O7 (604.2645345999999)
A tetrapeptide composed of L-aspartic acid, two L-tryptophan units and L-valine joined in sequence by peptide linkages.
2-[[2-[[2-[[1-Azepanyl(oxo)methyl]amino]-4-methyl-1-oxopentyl]amino]-3-(1-methyl-3-indolyl)-1-oxopropyl]amino]-3-(2-pyridinyl)propanoic acid
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
2-[[(5S,6R,9R)-5-methoxy-14-[[(2-methoxyanilino)-oxomethyl]amino]-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-8-yl]methyl]benzoic acid
3-[3-[(3R)-2-[(R)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[4-morpholinyl(oxo)methyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]-N,N-dimethylbenzamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
1-(1,3-benzodioxol-5-yl)-3-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
3-[3-[(3S)-2-[(S)-tert-butylsulfinyl]-3-(2-hydroxyethyl)-6-[4-morpholinyl(oxo)methyl]-1,3-dihydropyrrolo[3,4-c]pyridin-4-yl]phenyl]-N,N-dimethylbenzamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
1-(1,3-benzodioxol-5-yl)-3-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
1-(1,3-benzodioxol-5-yl)-3-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
1-(1,3-benzodioxol-5-yl)-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-2-[[(4-methoxyphenyl)methyl-methylamino]methyl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]cyclohexanecarboxamide
1-cyclohexyl-3-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]urea
[(1R,2R,3R,4S,5R,6S,7S,9R,10R,11S,14R,15R,16S,24S,26S)-10-hydroxy-9-(hydroxymethyl)-2,14,16-trimethyl-12-oxo-4-prop-1-en-2-yl-8,13,25,27,28,29-hexaoxaoctacyclo[13.10.1.14,24.15,24.111,14.01,6.07,9.011,26]nonacosan-3-yl] acetate
[(1R,2R,3R,4S,5R,6S,7S,9R,10R,11S,14R,15R,16R,24S,26S)-10-hydroxy-9-(hydroxymethyl)-2,14,16-trimethyl-12-oxo-4-prop-1-en-2-yl-8,13,25,27,28,29-hexaoxaoctacyclo[13.10.1.14,24.15,24.111,14.01,6.07,9.011,26]nonacosan-3-yl] acetate
[1-[(2-hexanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-[(2-acetyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate
[1-hydroxy-3-[hydroxy-(3-hydroxy-2-octanoyloxypropoxy)phosphoryl]oxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-[(2-butanoyloxy-3-hydroxypropoxy)-hydroxyphosphoryl]oxy-3-hydroxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-hexanoyloxypropan-2-yl] (9Z,12Z,15Z)-octadeca-9,12,15-trienoate
[1-butanoyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (11Z,14Z,17Z)-icosa-11,14,17-trienoate
[1-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxy-3-octanoyloxypropan-2-yl] (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate
[1-acetyloxy-3-[2,3-dihydroxypropoxy(hydroxy)phosphoryl]oxypropan-2-yl] (10Z,13Z,16Z)-docosa-10,13,16-trienoate
[1-phosphonooxy-3-[(5E,8E,11E)-tetradeca-5,8,11-trienoyl]oxypropan-2-yl] (5E,7E,9E,11E,13E)-hexadeca-5,7,9,11,13-pentaenoate
Cyclic GMP (TBAOH)
Cyclic GMP TBAOH is a tetra-n-butylammonium hydroxide (TBAOH) form of Cyclic GMP (HY-12512). Cyclic GMP is an endogenous second messenger that regulates a variety of cellular processes including apoptosis, vasodilation, and neurotransmission through the activation of signaling pathways such as Protein Kinase G in cells[1].
(1s,2r,4s,5r,6r,7r,9r,12r)-4,5-bis(acetyloxy)-2,6,10,10-tetramethyl-7-{[(2e)-3-phenylprop-2-enoyl]oxy}-11-oxatricyclo[7.2.1.0¹,⁶]dodecan-12-yl benzoate
[(1s,3r,4s,5s,7r,9r,10s,11s,12r)-10-(furan-3-yl)-11-hydroxy-8-[(2-hydroxy-3-methylbutanoyl)oxy]-4-[(2r,3r)-2-(hydroxymethyl)-2-methyl-5-oxooxolan-3-yl]-4,9-dimethyl-2-methylidene-6,13-dioxatetracyclo[7.4.0.0¹,¹².0³,⁷]tridecan-5-yl]acetic acid
methyl (2s)-2-[(1r,2s,5s,6s,10s,11r,12s,13s,14s,15s,17r,18r)-12,14-bis(acetyloxy)-6-(furan-3-yl)-11,17-dihydroxy-1,5,15-trimethyl-8-oxo-7-oxapentacyclo[13.2.1.0²,¹¹.0⁵,¹⁰.0¹³,¹⁷]octadecan-18-yl]-2-hydroxyacetate
1-[(8r,21r)-13-hydroxy-16,27-dimethoxy-22-methyl-29,31-dioxa-7,22-diazaoctacyclo[19.9.3.1⁴,³⁰.1¹⁰,¹⁴.1¹⁵,¹⁹.0³,⁸.0²⁵,³³.0²⁸,³²]hexatriaconta-1(30),2,4(34),10,12,14(36),15(35),16,18,25,27,32-dodecaen-7-yl]ethanone
C37H36N2O6 (604.2573236000001)